check_circleStudy Completed
Erectile Dysfunction
Bayer Identifier:
11333
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Evaluating the efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in subjects with erectile dysfunction (ED)
Trial purpose
Evaluating the efficacy of 10mg vardenafil versus 10mg tadalafil in the first 45 minutes post-dosing, in an as-required regimen for 4 weeks in subjects with mild/moderate to severe ED
Key Participants Requirements
Sex
MaleAge
18 - 64 YearsTrial summary
Enrollment Goal
759Trial Dates
April 2004 - July 2004Phase
Phase 4Could I Receive a placebo
NoProducts
Levitra (Vardenafil, BAY38-9456)Accepts Healthy Volunteer
NoPrimary Outcome
- Sexual Encounter Profile Question 3 (SEP-3)date_rangeTime Frame:4 weeksenhanced_encryptionnoSafety Issue:
Secondary Outcome
- Sexual Encounter Profile Question 2 (SEP-2)date_rangeTime Frame:4 weeksenhanced_encryptionnoSafety Issue:
- International Index of Erectile Functiondate_rangeTime Frame:4 weeksenhanced_encryptionnoSafety Issue:
- Global Confidence Question (GCQ)date_rangeTime Frame:4 weeksenhanced_encryptionnoSafety Issue:
- Erection Quality Scale (EQS)date_rangeTime Frame:4 weeksenhanced_encryptionnoSafety Issue:
- General Safetydate_rangeTime Frame:4 weeksenhanced_encryptionyesSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
TreatmentAllocation
RandomizedBlinding
Double BlindAssignment
Parallel AssignmentTrial Arms
2